AptaBio Therapeutics Inc. (KOSDAQ: 293780)
South Korea
· Delayed Price · Currency is KRW 6,310.00
-100.00 (-1.56%)
Nov 15, 2024, 9:00 AM KST
AptaBio Therapeutics Market Cap
AptaBio Therapeutics has a market cap or net worth of 156.79 billion as of November 18, 2024. Its market cap has decreased by -13.41% in one year.
Market Cap
156.79B
Enterprise Value
124.19B
Revenue
2.06B
Ranking
n/a
PE Ratio
n/a
Stock Price
6,310.00
Market Cap Chart
Since June 12, 2019, AptaBio Therapeutics's market cap has decreased from 423.30B to 156.79B, a decrease of -62.96%. That is a compound annual growth rate of -16.71%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 15, 2024 | 156.05B | -22.67% |
| Dec 28, 2023 | 201.80B | -15.02% |
| Dec 29, 2022 | 237.48B | -71.24% |
| Dec 30, 2021 | 825.71B | 46.50% |
| Dec 30, 2020 | 563.64B | 49.70% |
| Dec 30, 2019 | 376.51B | -11.05% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition